In this presentation from the Lymphoma & Myeloma 2017, Dr. Adam D. Cohen discusses the future of multiple myeloma therapy, with a specific focus on BITE immunotherapy, CAR-T, and immune checkpoint inhibitors.

Earn CME credit for a related activity at the following location:
http://elc.imedex.com/ELC/Specialty-Search.aspx?search=hematology

© 2017 Imedex, LLC.

Leave a Reply

Let us help fight cancer. Share your knowledge.

About

Latest news, views, insights and trends on cancer treatment, discovery and support

Navigation